Pharmaceutical Industry Information Portal

Congo declares new Ebola outbreak in north-western province

A new case of Ebola has been confirmed in northwestern Democratic Republic of Congo, prompting health authorities to enforce urgent containment measures just four months after the previous outbreak came to an end.

Ebola is a virus that causes problems with how your blood clots. It is known as a hemorrhagic fever virus, because the clotting problems lead to internal bleeding, as blood leaks from small blood vessels in your body. The virus also causes inflammation and tissue damage.

The case, a 31-year old male, was detected in the city of Mbandaka, capital of Congo’s Equateur province. Around 74 of his contacts are being tracked, the health ministry said in a statement. The patient began showing symptoms on April 5, but did not seek treatment for more than a week, the World Health Organization (WHO) said in a statement. He was admitted to an Ebola treatment centre on April 21 and died later that day.

“Time is not on our side,” said Dr Matshidiso Moeti, the WHO’s Regional Director for Africa. “The disease has had a two-week head start and we are now playing catch-up.”

Mbandaka, a trading hub on the banks of the Congo River, has contended with two previous outbreaks  in 2018 and in 2020. It is a city where people live in close proximity, with road, water and air links to the capital Kinshasa.

The WHO said that efforts to contain the disease are already underway in Mbandaka, and that a vaccination campaign will begin in the coming days.

Vaccines have been increasingly important in curbing recent Ebola outbreaks. Health authorities vaccinated more than 1,800 people using Merck’s ERVEBO vaccine amid the last flare-up.

spot_img

Expert Articles

spot_img